About this event
- Date and time Wed 11 Nov 2026 from 10:00am to 4:45pm
- Location Online
- Organised by Food and Health
Join the Royal Society of Medicine (RSM) Food and Health Forum for this full day webinar exploring the relationship between diet, neurobehavioural function and GLP-1 receptor agonist (GLP-1 RA) therapy. Bringing together leading experts in obesity, metabolism, nutrition and neurobiology, the programme will examine how diet influences health outcomes, weight trajectories and brain function during and after treatment, while addressing some of the most important unanswered questions in obesity care.
The use of GLP-1 receptor agonists has transformed the treatment landscape for obesity and metabolic disease. However, despite rapidly growing use, there remains little clear evidence-based dietary guidance to support patients during treatment or after therapy ends. At the same time, clinicians and researchers continue to explore the longer-term effects of these treatments on appetite regulation, reward processing, eating behaviour and weight regain following cessation. As newer dual and triple agonists emerge and oral therapies increase access to treatment, understanding these issues is becoming increasingly important for clinical practice.
Why attend?
- Hear from internationally recognised experts including Professor Jens Juul Holst, Professor Sadaf Farooqi, Professor Giles Yeo, Professor Susan Jebb and Professor John Wilding
- Explore current evidence on diet, health outcomes and weight management during and after GLP-1 receptor agonist therapy
- Gain insight into the neurobiological mechanisms underlying appetite regulation, reward pathways and eating behaviour, and explore the challenges associated with treatment cessation and weight regain
- Understand how emerging dual and triple agonist therapies may influence future obesity management
- Put your questions directly to expert panels during dedicated discussion sessions
Aims of the event
- Provide an evidence-based overview of diet and neurobehavioural function during and after GLP-1 receptor agonist therapy
- Explore the metabolic, behavioural and clinical factors influencing treatment outcomes and cessation
- Support healthcare professionals in applying emerging evidence to obesity management and patient care
Learning outcomes
By attending this webinar, participants will be able to:
- Evaluate current perspectives on GLP-1 receptor agonist therapies in obesity management, including their role as long-term metabolic tools
- Describe the neurobiological and behavioural mechanisms associated with appetite regulation, reward pathways and eating behaviour during GLP-1 therapy
- Evaluate emerging evidence on diet, treatment cessation, weight regain and future approaches to obesity management
Who should attend?
This webinar is suitable for:
- Obesity specialists, endocrinologists and metabolic medicine physicians
- Dietitians, nutritionists and advanced practitioners in weight management
- Clinical psychologists and neuropsychologists working in eating behaviour and obesity
- Academic researchers working across obesity, nutrition, neurobiology and metabolic health
- Healthcare professionals with an interest in GLP-1 therapies, treatment cessation and weight management
- Industry stakeholders including pharmaceutical developers, digital health companies and nutrition and food sector professionals with an interest in metabolic health innovation
Tickets
Standard pricing available until 10 November 2026.
Member
| RSM Associate | RSM Fellow | RSM Resident Doctor | RSM Retired Fellow | RSM Student |
|---|---|---|---|---|
| £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
Non - Member
| Consultant / GP / SAS Doctors | Other HCPs | Resident Doctor | Student |
|---|---|---|---|
| £66.00 | £50.00 | £50.00 | £33.00 |
Agenda
View the programme
Welcome and introduction
Chair: Professor Lauren Owen, Cognitive and Behavioural Neuroscience, School of Humanities and Social Sciences, Leeds Beckett University
Keynote address
Professor Jens Juul Holst, Professor at the Department of Biomedical Sciences affiliated with the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Session 1: GLP1-RA: Metabolism, diet and disease
Professor Sadaf Farooqi, Professor of Metabolism and Medicine, University of Cambridge
Professor Nita Forouhi, Professor of Metabolism and Medicine, NIHR Cambridge Biomedical Campus Theme Lead, University of Cambridge
Professor John Wilding, Professor of Cardiometabolic & Metabolic Medicine, University of Liverpool
Panel discussion and Q&A
Lunch
Session 2. GLP-1RA: Neurobiology of appetite, behaviour and psychobiology
Welcome back and introduction
Professor Giles Yeo, Professor of Molecular Neuroendocrinology, Scientific Director of Genomics Bioinformatics Core, University of Cambridge
Professor Stefan Trapp, Professor of Autonomic Neuroscience and Metabolic Disease, University College London
Beyond appetite suppression: how GLP-1 receptor agonists influence food reward, cravings and eating behaviour
Professor Graham Finlayson, Professor of Psychobiology, University of Leeds
Panel discussion and Q&A
Session 3. GLP1-RA: Clinical and translational perspectives
Professor Susan Jebb, Professor of Diet and Population Health, University of Oxford Obesity
Professor Louisa Ells, Professor of Obesity, Director of the Obesity Institute, Leeds Beckett University
Close of meeting
Location
Online
In-person registration closes at 1:00am on 11 November 2026. Late registrations will not be accepted.
The agenda is subject to change at any time
If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM's discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speakers' organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.